[{"Assets_0_Q2_USD":58195100.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-4183191.0,"NetIncomeLoss_2_Q2_USD":-8088370.0,"NetIncomeLoss_1_Q2_USD":-3831217.0,"StockholdersEquity_0_Q2_USD":41331218.0,"Ticker":"VERU","CIK":"863894","name":"VERU INC.","OfficialName":"Veru Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1011836411.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180511"}]